Descrizione

Histological improvement in ulcerative colitis patients treated with curcumin is assessed across available trials. Mucosal healing markers suggest potential tissue-level benefits from supplementation.

Figure 11

Chart

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 11: Histological improvement in ulcerative colitis patients treated with curcumin is assessed across available trials. Mucosal healing markers suggest potential tissue-level benefits from supplementation.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Histological improvement in ulcerative colitis patients treated with curcumin is assessed across available trials. Mucosal healing markers suggest potential tissue-level benefits from supplementation." />
  <figcaption>Figure 11. Histological improvement in ulcerative colitis patients treated with curcumin is assessed across available trials. Mucosal healing markers suggest potential tissue-level benefits from supplementation.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

Evidenze correlate

Curcumin per Ulcerative Colitis (UC)

Grado B · 5 studi

Curcumin per Crohn's Disease

Grado C · 3 studi